Shares declined 2.4% following the report, reflecting investor caution despite solid leasing in outpatient medical and growth in senior housing, likely due to margin pressures and a tempered outlook on near-term growth acceleration.
- FFO as adjusted came in at $0.46 per share with net debt-to-EBITDA of 4.7x, indicating a stable but leveraged balance sheet.
- Outpatient medical leasing remained strong with 1.2 million square feet executed in Q2, including 327,000 square feet of new leases, continuing positive momentum.
- Senior housing same-store occupancy increased by 260 basis points while NOI grew 19%, driven by Janus Living’s accelerating footprint and unique deal structure.
- The company completed a $1 billion strategic partnership with Brookfield on outpatient medical assets, providing capital recycling and expanding alternative equity capital sources.
- Management highlighted cautious capital allocation and patience on acquisitions or buybacks given current market conditions and the cost of debt relative to cap rates.
Community Discussion